Results 181 to 190 of about 92,853 (340)

Does digoxin decrease morbidity for those in sinus rhythm with heart failure? [PDF]

open access: yes, 2005
In patients with congestive heart failure due to systolic dysfunction who are in normal sinus rhythm, digoxin therapy reduces rates of hospitalization, as well as clinical deterioration, defined as worsening New York Heart Association (NYHA ...
Fotinos, Charissa, Nashelsky, Joan
core  

Clinical Significance and Management of Atrioventricular Block Associated With Bradycardic/Antiarrhythmic Drug Therapy: Drug‐Induced or Drug‐Revealed?

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Schematic representation of the management pathway in drug‐related advanced atrioventricular block. ABSTRACT The development of advanced atrioventricular block (AVB) in patients on bradycardic and/or antiarrhythmic therapy (drug‐related AVB) represents a clinical challenge, raising the question of whether the AVB is directly caused by these agents ...
Dimitrios Sfairopoulos   +7 more
wiley   +1 more source

Individual dosage of digoxin in patients with heart failure [PDF]

open access: yes, 2017
Backgroud: After the publication of DIG trial, the therapeutic target of serum digoxin concentration (SDC) for the treatment of heart failure (HF) has been lowered (0.40-1.00 ng/ml).
Brunner-La Rocca, H.   +6 more
core  

Temporary Restoration of Sinus Rhythm Improves Outcomes of Catheter Ablation for Longstanding Persistent Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Atrial arrhythmia free survival following catheter ablation according to temporary restoration of sinus rhythm attempt. Abbreviation: TRSR, temporary restoration of sinus rhythm. ABSTRACT Background Long‐standing persistent atrial fibrillation (LSPAF) is associated with adverse atrial structural and electrical remodeling, limiting the success of ...
Mohamad Raad   +21 more
wiley   +1 more source

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

open access: yesAmyloid: Journal of Protein Folding Disorders, 2018
Eli Muchtar   +13 more
semanticscholar   +1 more source

Deprescribing Benzodiazepine Receptor Agonists in Older Adults and People With Cognitive Impairment: A Systematic Review

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Benzodiazepine receptor agonists (BZRAs) (benzodiazepines and z‐drugs) may provide limited benefits in the management of insomnia when used short‐term. However, they increase the risk of harms including falls, fractures, hospitalizations, and cognitive impairment. Deprescribing (cessation) of BZRAs may be beneficial for older adults
Aisling M. McEvoy   +5 more
wiley   +1 more source

A Prospective Analysis of Adverse Drug Reactions in a South Indian Hospital [PDF]

open access: yes, 2009
Adverse drug reactions are a great cause of concern to the medical profession, the patients and the pharmaceutical industry. However ADR reporting and monitoring is yet to catch up in India.
Adhikari, P, Padmaja, U, Pereira, P
core  

Use of dipeptidyl peptidase‐4 inhibitors is associated with lower risk of severe renal outcomes in pre‐dialysis patients with Type 2 diabetes

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Objectives Patients with diabetes and Stage 5 chronic kidney disease (CKD) not on dialysis are susceptible to renal replacement therapy and severe complications. Among limited antidiabetic options in this vulnerable population, dipeptidyl peptidase‐4 (DPP‐4) inhibitors (DPP‐4i) are widely used; however, supporting evidence is scant.
Tung‐Ying Hung   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy